Horton Capital Management News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Horton capital management. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Horton Capital Management Today - Breaking & Trending Today

Retail investors account for 39% of KORU Medical Systems, Inc.'s (NASDAQ:KRMD) ownership, while institutions account for 32%

Key Insights KORU Medical Systems' significant retail investors ownership suggests that the key decisions are. ....

Linda Tharby , Horton Capital Management , Systems Inc , Koru Medical Systems , Koru Medical Systems , Institutional Investors , Retail Investors ,

KORU Medical Systems, Inc. (NASDAQ:KRMD) has caught the attention of institutional investors who hold a sizeable 34% stake

Key Insights Significantly high institutional ownership implies KORU Medical Systems' stock price is sensitive to their. ....

Linda Tharby , Systems Inc , Horton Capital Management , Koru Medical Systems , Nstitutional Ownership , Koru Medical Systems , Institutional Investors , Ndividual Investors ,

Repro Med Systems, Inc. (NASDAQ:KRMD) Director Joseph M. Jr. Manko Acquires 20,000 Shares

Repro Med Systems, Inc. (NASDAQ:KRMD – Get Rating) Director Joseph M. Jr. Manko purchased 20,000 shares of the stock in a transaction on Thursday, May 12th. The stock was acquired at an average price of $2.01 per share, for a total transaction of $40,200.00. Following the completion of the purchase, the director now directly owns […] ....

United States , Josephm Jr , Securities Exchange Commission , Repro Med Systems Inc , Zacks Investment Research , Parkman Healthcare Partners , Horton Capital Management , B Riley Asset Management , Repro Med Systems , Get Rating , Director Joseph , Exchange Commission , Med Systems , Riley Asset Management , Capital Management , Healthcare Partners , Investment Management , Altium Capital Management , Nasdaq Krmd , Insider Trading , Nsider Trades ,

Equities Analysts Set Expectations for UroGen Pharma Ltd.'s Q1 2022 Earnings (NASDAQ:URGN)

UroGen Pharma Ltd. (NASDAQ:URGN – Get Rating) – Investment analysts at Jefferies Financial Group issued their Q1 2022 earnings per share (EPS) estimates for shares of UroGen Pharma in a research note issued on Monday, March 21st. Jefferies Financial Group analyst C. Howerton anticipates that the company will post earnings of ($1.58) per share for […] ....

Thomson Reuter , Urogen Pharma , Elizabetha Barrett , Harel Insurance Investments Financial Services Ltd , Securities Exchange Commission , Zacks Investment Research , Blackrock Inc , Horton Capital Management , Urogen Pharma Ltd , Great Point Partners , Jefferies Financial Group , Goldman Sachs Group , Get Rating , Financial Group , Gen Pharma , Insurance Investments , Financial Services , Point Partners , Capital Management , Exchange Commission , Nasdaq Urgn , Earnings Estimates , Jefferies Financial Group Inc ,